EquityZen Growth Technology Fund II LLC - Series 25 (CIK: 0002061905) EDGAR, Information, Filings... CompaniesBIO.Com

EquityZen Growth Technology Fund II LLC - Series 25

Mailing address
30 BROAD STREET, SUITE 1200, NEW YORK, Delaware, 10004
Phone
8774906121
State location
New York
State of incorporation
Delaware
Fiscal year end
December 31
SIC
N/A
Filings
N/A

EquityZen Growth Technology Fund II LLC - Series 25 (CIK: 0002061905) is an American company incorporated in the state of New York. Head office is located at 30 BROAD STREET, SUITE 1200, NEW YORK, New York, 10004. Work in the industry N/A. EquityZen Growth Technology Fund II LLC - Series 25 is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by EquityZen Growth Technology Fund II LLC - Series 25

Filings	Format	Description	Filed/Effective	File/Film Number
D	Document	Acc-no: 0002061905-25-000001 (33 Act) Size: KB	Aug-26-2025	021-555793 251254155

Recent 20 filings. View all EquityZen Growth Technology Fund II LLC - Series 25 filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

EquityZen Growth Technology Fund II LLC - Series 25 overview
EquityZen Growth Technology Fund II LLC - Series 25 job
EquityZen Growth Technology Fund II LLC - Series 25 stock
EquityZen Growth Technology Fund II LLC - Series 25 ownership
EquityZen Growth Technology Fund II LLC - Series 25 CEO
EquityZen Growth Technology Fund II LLC - Series 25 documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.